A smartphone program aims to ease the emotional toll of fertility loss in young cancer survivors

NCT ID NCT07729696

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether a guided digital program delivered through a mobile app can reduce anxiety and depression in young adults (ages 18–40) who have fertility-related distress after a cancer diagnosis. Participants use the app to complete four modules covering coping skills, self-efficacy, and social support. The study compares the program against usual care to see if it improves emotional well-being and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a digital psychoeducational program delivered via a mobile app with e-booklets, videos, and quizzes
What this could lead to
If effective, this digital program could offer a scalable way to help young cancer survivors manage fertility-related distress and improve their quality of life.
What could go wrong
This is a small, early-stage trial with only 38 participants, so results may not apply broadly. The intervention requires active engagement, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bali Mandara Genderal Hospital

    Denpasar, Bali, 81113, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.